Score Pharma
1 known investors
Score Pharma is a biotech company developing biosuperior antibody therapeutics aimed at cancer treatment.
Investors · 1
Competitors · 2
by search overlapSutrobio3 shared keywordsSutro develops a next-generation antibody-drug conjugate (ADC) platform for single- and dual-payload therapeutics aimed at treating cancer patients. It operates in the oncology-focused biotech and drug development industry.
35Pharma3 shared keywords35Pharma is a biopharmaceutical company that designs and develops ligand traps targeting the Activin x GDF signaling pathway to treat pulmonary hypertension, heart failure, and obesity. Its lead candidate, HS235, is in clinical development for cardiometabolic disease and pulmonary hypertension; the company has been acquired by GSK.
Companies competing with Score Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Score Pharma do?
- Score Pharma is a biotech company developing biosuperior antibody therapeutics aimed at cancer treatment.
- Who are Score Pharma's investors?
- Score Pharma's investors include The Innovation Space.